ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Exploiting conformational dynamics in drug discovery: design of C-terminal inhibitors of Hsp90 with improved activities
dc.contributor.author | Moroni, Elisabetta | |
dc.contributor.author | Zhao, Huiping | |
dc.contributor.author | Blagg, Brian S. J. | |
dc.contributor.author | Colombo, Giorgio | |
dc.date.accessioned | 2017-05-16T18:55:35Z | |
dc.date.available | 2017-05-16T18:55:35Z | |
dc.date.issued | 2014-01-27 | |
dc.identifier.citation | Moroni, E., Zhao, H., Blagg, B. S. J., & Colombo, G. (2014). Exploiting conformational dynamics in drug discovery: design of C-terminal inhibitors of Hsp90 with improved activities. Journal of Chemical Information and Modeling, 54(1), 195–208. http://doi.org/10.1021/ci4005767 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/24228 | |
dc.description.abstract | The interaction that occurs between molecules is a dynamic process that impacts both structural and conformational properties of the ligand and the ligand binding site. Herein, we investigate the dynamic cross-talk between a protein and the ligand as a source for new opportunities in ligand design. Analysis of the formation/disappearance of protein pockets produced in response to a first-generation inhibitor assisted in the identification of functional groups that could be introduced onto scaffolds to facilitate optimal binding, which allowed for increased binding with previously uncharacterized regions. MD simulations were used to elucidate primary changes that occur in the Hsp90 C-terminal binding pocket in the presence of first-generation ligands. This data was then used to design ligands that adapt to these receptor conformations, which provides access to an energy landscape that is not visible in a static model. The newly synthesized compounds demonstrated anti-proliferative activity at ~150 nanomolar concentration. The method identified herein may be used to design chemical probes that provide additional information on structural variations of Hsp90 C-terminal binding site. | en_US |
dc.publisher | American Chemical Society | en_US |
dc.rights | This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Chemical Information and Modeling, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see http://doi.org/10.1021/ci4005767. | en_US |
dc.subject | Drug-Design | en_US |
dc.subject | Flexibility | en_US |
dc.subject | Allostery | en_US |
dc.subject | MD simulations | en_US |
dc.subject | Dynamics-Based Design | en_US |
dc.subject | Hsp90 | en_US |
dc.title | Exploiting conformational dynamics in drug discovery: design of C-terminal inhibitors of Hsp90 with improved activities | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Zhao, Huiping | |
kusw.kuauthor | Blagg, Brian S. J. | |
kusw.kudepartment | Medicinal Chemistry | en_US |
dc.identifier.doi | 10.1021/ci4005767 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.rights.accessrights | openAccess |